Search

Search Constraints

You searched for: Author/Creator Rödel, Claus

Search Results

41. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Issue 8 (August 2015)

42. Professional Medical Writer Assistance in Oncology Clinical Trials. (17th September 2020)

43. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer. (December 2020)

44. Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy. Issue 2 (February 2018)

45. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. (September 2020)

46. Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial. (February 2021)

47. RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial. (July 2020)

48. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives. (January 2023)

49. Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial. (March 2020)

50. Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study. (May 2021)